Skip to main content

Table 4 Multivariable analyses of risk factors of pneumothorax in STS patients during pazopanib treatment

From: Risk factors for pneumothorax in advanced and/or metastatic soft tissue sarcoma patients during pazopanib treatment: a single-institute analysis

Variate Adjusted Odds ratio 95 % CI p-value
Maximum dia. of lung lesions ≥ 30 mm 13.3 1.1–155.4 0.039
History of pneumothorax 16.6 1.1–256.1 0.045